Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-04

Clinical Trial Update: Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating affect recognition training for people with acquired brain injury, including stroke, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University at Buffalo | Conditions: Acquired Brain Injury (Including Stroke) | Phase 2, Phase 3 | Status: COMPLETED